Michael Yu, M.D.
Alvin & Lois Lapidus Cancer Institute at Sinai and Northwest Hospitals
Michael Yu, M.D., is board-certified in radiation oncology. His subspecialty areas of interest include image-guided radiation therapy, re-irradiation, stereotactic ablative radiation therapy and stereotactic radiosurgery.
Yu HM, Song DY, Tsai Y, Thompson T, Frassica DA, DeWeese TL. Perineural invasion impacts biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiation therapy. Urology. 2007 July;70(1):111-6.
Scott J, Tsai Y, Chinnaiyan P, Yu HM. Effectiveness of radiotherapy in elderly patients with glioblastoma. Int J Radiat Oneal Bio Phys. 2011 Sep 1;81(1):206-10. Epub 2010 Aug 2.
Rao NO, Yu HM, Trotti A, Sondak VK. The role of radiation therapy in the management of cutaneous melanoma. Surg Oneal Clin N Am. 2011 Jan;20(1):115-31.
Wang J, Hung S, Hui Y, Wang S, Yu HM, Huang Y, Chiang E, Lin C, Chen T. Recapitulation of fibromatosis nodule by multipotential stem cells in immunodeficient mice. PLoS One. 2011;6(8):e24050. Epub 2011 Aug 25.
Yu HM, Hoffe S. Beyond the conventional role of external beam radiation therapy for skeletal metastases: new technologies and stereotactic directions. Cancer Control. Accepted 2011.
Chinnaiyan P, Chowdhary S, Pothast L, Prabhu A, Tsai Y, sarcar B, Kahali S, BremS, Yu HM, Rogiani A, Murtagh R, Pan E. Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma. Neuro-Oncology. Accepted 2011.
Yu HM, Tsai Y, Hoffe S. Overview of Diagnostic and Therapeutic Intervention for Metastatic Disease to the Bone. Cancer Control. Accepted 2011.
Zhang GG, Ku L, Yu HM, Sarangkasiri S, Zhang RR, Li W, Feygelman V. Dosimetric analysis of modulated arcs in stereotactic radiosurgery. Journal of Radiosurgery and SBRT. Accepted 2011.
DeVito N, Yu HM, Chen R, Pan E. Retrospective study of patients with melanoma brain metastases receiving concurrent whole brain radiotherapy and temozolomide. Anticancer Research. Accepted 2001.
Lim Y, Hedayati M, Merchant A, Zhang Y, Yu HM, Kastan MB, Matsui W, DeWeese TL. Chloroquine improves hematopoietic recovery and survival following lethal low dose-rate radiation. Int J Radiat Oncol Bio Phys. Accepted 2012.
Yu HM, Tsai Y. Clinicopathological characteristics and outcomes of gliosarcoma. In preparation.
Book Chapters [+/-]
Page D, Scott J, Yu HM. Principles of Radiotherapy for Gliomas: Symptoms, Diagnosis, and Treatment Options. Nova Science Publishers. 2012. In press.
Back to top